Publicaciones en colaboración con investigadores/as de Hospital Universitario San Cecilio (21)

2022

  1. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12

  2. Guidelines on the management of mineral and bone metabolism disorders during pregnancy and lactation

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 7, pp. 530-539

2021

  1. Executive summary: Position document: Evaluation and management of hypoglycemia in the patient with diabetes mellitus 2020. Diabetes Mellitus Working Group of the Spanish Society of Endocrinology and Nutrition

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 4, pp. 270-276

  2. SARS-CoV-2 infection in patients with primary Sjögren syndrome: Characterization and outcomes of 51 patients

    Rheumatology (United Kingdom), Vol. 60, Núm. 6, pp. 2946-2957

2020

  1. New technologies in the evaluation of bone fragility and its application in Endocrinology

    Endocrinologia, Diabetes y Nutricion, Vol. 67, Núm. 9, pp. 602-610

  2. Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)

    Breast, Vol. 54, pp. 286-292

  3. Phosphate disorders and clinical management of hypophosphatemia and hyperphosphatemia

    Endocrinologia, Diabetes y Nutricion, Vol. 67, Núm. 3, pp. 205-215

2016

  1. Long-term adherence to IFN beta-1a treatment when using rebismart1device in patients with relapsing-remitting multiple sclerosis

    PLoS ONE, Vol. 11, Núm. 8

  2. Validation of PHPQoL, a disease-specific quality-of-life questionnaire for patients with primary hyperparathyroidism

    Journal of Clinical Endocrinology and Metabolism, Vol. 101, Núm. 4, pp. 1571-1578

2015

  1. Circulating sclerostin and estradiol levels are associated with inadequate response to bisphosphonates in postmenopausal women with osteoporosis

    Maturitas, Vol. 82, Núm. 4, pp. 402-410

2014

  1. Documento de consenso: Recomendaciones para el manejo de la enfermedad ósea metabólica en pacientes con virus de la inmunodeficiencia humana

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 32, Núm. 4, pp. 250-258

2013

  1. Vitamin D hormone system and diabetes mellitus: Lessons from selective activators of vitamin D receptor and diabetes mellitus

    Endocrinologia y Nutricion

2012

  1. Fe de errores de "Guías de práctica clínica para la evaluación y tratamiento de la osteoporosis asociada a enfermedades endocrinas y nutricionales"

    Endocrinologia y Nutricion

  2. Results from a national survey on the management of primary hyperparathyroidism

    Journal of Endocrinological Investigation, Vol. 35, Núm. 11, pp. 957-963

  3. Risk factors for prediction of inadequate response to antiresorptives

    Journal of Bone and Mineral Research, Vol. 27, Núm. 4, pp. 817-824

2010

  1. CD40: Novel association with crohn's disease and replication in multiple sclerosis susceptibility

    PLoS ONE, Vol. 5, Núm. 7, pp. 1-4

2009

  1. Addendum

    Endocrinologia y Nutricion, Vol. 56, Núm. SUPPL. 1, pp. 48-49

  2. Editorial

    Endocrinologia y Nutricion

  3. Risk factors among women with osteoporosis treated in primary health care and in hospitals

    Revista Clinica Espanola, Vol. 209, Núm. 7, pp. 319-324

2007

  1. Osteoporosis: Report of the Working Group for Bone and Mineral Metabolism of the Spanish Society of Endocrinology and Nutrition

    Endocrinologia y Nutricion, Vol. 54, Núm. 1, pp. 53-61